Our Work

Whole Genome Sequencing through the NHS

Last Reviewed 5/11/2018

Genetic Alliance UK have conducted a survey, in association with Genomics England, aimed at patients with a rare or undiagnosed condition and their carers.


We aim to understand patients’ and carers’ views about whole genome sequencing and its introduction as part of routine NHS care.
Whole genome sequencing (WGS) is a technology which looks at all of the genetic code in a cell in the hope of uncovering new understanding about the causes and best treatments for diseases. WGS promises to help increase understanding of rare inherited diseases and cancer in order to improve care and diagnosis. Earlier this year NHS England and Genomics England announced the launch of a national Genomic Medicine Service. This will see the introduction of WGS as part of routine care for patients with certain rare conditions, undiagnosed conditions, and cancer. This is following on from their previous work, the 100,000 Genomes Project, a research project that aimed to sequence 100,000 whole genomes of patients affected with certain rare and undiagnosed conditions, and also cancers, which is due to close this year.


Genomics England has commissioned Genetic Alliance UK to seek the views of patients and carers around the introduction of WGS into the NHS. They would also like to hear about people’s experiences of taking part in the 100,000 Genomes Project. This information will be used by Genomics England to inform the launch of mainstream WGS, as part of the new Genomic Medicine Service.

The survey is now closed, and we are processing the results.

Join our alliance of 200+ patient charities

Join us